144 related articles for article (PubMed ID: 35420266)
1. Is there a relationship between preoperative cytological diagnosis and evolution in patients with differentiated thyroid carcinoma? A retrospective study.
Colenci R; Minicucci MF; Soares CSP; de Oliveira CC; de Alencar Marques ME; Tagliarini JV; da Silva Mazeto GMF
Arch Endocrinol Metab; 2022 Apr; 66(2):237-246. PubMed ID: 35420266
[TBL] [Abstract][Full Text] [Related]
2. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative frozen section can be reduced in thyroid nodules classified as Bethesda categories V and VI.
Huang J; Luo J; Chen J; Sun Y; Zhang C; Xu K; Ye Q; Huang P
Sci Rep; 2017 Jul; 7(1):5244. PubMed ID: 28701706
[TBL] [Abstract][Full Text] [Related]
4. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
5. Thyroglobulin is a poor predictor of differentiated thyroid cancer in patients who undergo surgery for thyroid nodular diseases.
Rigbi S; Joshua BZ; Baraf L; Yoel U; Fraenkel M
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1311-1319. PubMed ID: 36205785
[TBL] [Abstract][Full Text] [Related]
6. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.
Yip L; Wharry LI; Armstrong MJ; Silbermann A; McCoy KL; Stang MT; Ohori NP; LeBeau SO; Coyne C; Nikiforova MN; Bauman JE; Johnson JT; Tublin ME; Hodak SP; Nikiforov YE; Carty SE
Ann Surg; 2014 Jul; 260(1):163-8. PubMed ID: 24901361
[TBL] [Abstract][Full Text] [Related]
7. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
Sanabria A
Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
[No Abstract] [Full Text] [Related]
8. Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone.
Essig GF; Porter K; Schneider D; Debora A; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas L; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT
Endocr Pract; 2013; 19(6):920-7. PubMed ID: 23757627
[TBL] [Abstract][Full Text] [Related]
9. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
Miseikyte-Kaubriene E; Ulys A; Trakymas M
Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
[TBL] [Abstract][Full Text] [Related]
10. Fine Needle Aspiration Cytology and Thyroglobulin Antibodies in Preoperative Diagnosis of Thyroid Malignancy.
Hasukic B; Jakubovic-Cickusic A; Sehanovic E; Osmic H
Med Arch; 2019 Dec; 73(6):382-385. PubMed ID: 32082004
[TBL] [Abstract][Full Text] [Related]
11. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between the Bethesda system for thyroid nodules and post-thyroidectomy histopathological diagnosis].
Kraus-Fischer G; Alvarado-Bachmann R; Rienzo-Madero B; Núñez-García E; Peña MV; Zerrweck-López C
Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):114-121. PubMed ID: 34101555
[TBL] [Abstract][Full Text] [Related]
13. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
14. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
15. Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category.
Słowińska-Klencka D; Wysocka-Konieczna K; Woźniak-Oseła E; Sporny S; Popowicz B; Sopiński J; Kaczka K; Kuzdak K; Pomorski L; Klencki M
J Endocrinol Invest; 2019 Nov; 42(11):1319-1327. PubMed ID: 31077094
[TBL] [Abstract][Full Text] [Related]
16. Does bethesda category predict aggressive features in malignant thyroid nodules?
Kleiman DA; Beninato T; Soni A; Shou Y; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2013 Oct; 20(11):3484-90. PubMed ID: 23812773
[TBL] [Abstract][Full Text] [Related]
17. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules.
Sidoti M; Marino G; Resmini E; Augeri C; Cappi C; Cavallero D; Lagasio C; Ceppa P; Minuto F; Giusti M
Minerva Endocrinol; 2006 Jun; 31(2):159-72. PubMed ID: 16682939
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
19. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
